Future strategies to reduce the mortality rates for lung cancer may include chemoprevention with improved dietary agents, and improved screening based on molecular biological techniques to determine early genetic changes in exfoliated bronchial cells. New chemotherapeutic approaches will see the introduction of the Taxane drugs, the development of MDR (multidrug resistance) gene suppressor drugs and the use of liposomal coatings to improve the delivery of drugs and the targeting of tumour cells. Anti-angiogenesis agenst may also reduce tumour growth without actually being tumoricidal. However, above all, lung cancer is a smoking related disease and any major reduction in mortality from this disease will be from a reduction in cigarette smoking